JPRN-UMIN000036542尚未招募未知
Randomized Phase II study regarding treatment cycles of neo-adjuvant chemotherapy with biweekly triplet gemcitabine/cisplatin/s-1 for biliary tract cancer - KHBO-1902
KHBO0 个研究点目标入组 100 人开始时间: 2019年4月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Distant metastasis 2) Double cancer 3) Interstitial pneumonia 4) Waterly diarrhea 5) Active infection except for hepatitis and cholangitis 6) Several organ dysfunction (Heat failure, Renal failure, Liver failure, GI bleeding, Ileus, Uncontrolled DM) 7) Pregnancy 8) Psychic disorder 9) Allergy 10) Others
研究者
相似试验
进行中（未招募）
不适用
Randommized Phase II study of the continuous treatment vs. standard treatment with capecitabine in metastatic breast cancer patientsMETASTATIC BREAST CANCERMedDRA version: 7.0Level: LLTClassification code 10027475EUCTR2004-002759-15-ESDr. Miguel Martín
招募中
2 期
Does Olanzapine improve quality of life in incurable cancer patients?CTRI/2022/03/041155ational cancer Institute AIIMS
进行中（未招募）
1 期
A study to evaluate the switch from prednisone to dexamethasone in prostate cancer patients being treated with abirateroneEUCTR2021-000943-30-ESSOGUG (Spanish Genitourinary Oncologic Group)110
进行中（未招募）
1 期
_Patients with liver-only non resectable colorectal metastases.EUCTR2016-001493-15-FRICANCER140
进行中（未招募）
1 期
on-randomised phase II trial of Sequential Therapy of Imiquimod followed by Vaccination with TA CIN for High Grade VIVIN3EUCTR2005-001824-35-GBniversity of Manchester30